Christopher A. Boerner
2013
In 2013, Christopher A. Boerner earned a total compensation of $1.8M as Former EVP, Commercial at Seattle Genetics, a 1% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $164,496 |
|---|---|
| Option Awards | $673,203 |
| Salary | $354,050 |
| Stock Awards | $574,560 |
| Other | $8,612 |
| Total | $1,774,921 |
Boerner received $673.2K in option awards, accounting for 38% of the total pay in 2013.
Boerner also received $164.5K in non-equity incentive plan, $354.1K in salary, $574.6K in stock awards and $8.6K in other compensation.
Rankings
In 2013, Christopher A. Boerner's compensation ranked 4,292nd out of 12,286 executives tracked by ExecPay. In other words, Boerner earned more than 65.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,292 out of 12,286 | 65th |
Division Manufacturing | 1,465 out of 4,612 | 68th |
Major group Chemicals And Allied Products | 407 out of 1,462 | 72nd |
Industry group Drugs | 281 out of 1,156 | 76th |
Industry Biological Products, Except Diagnostic Substances | 40 out of 196 | 80th |
Source: SEC filing on April 6, 2015.
Boerner's colleagues
We found five more compensation records of executives who worked with Christopher A. Boerner at Seattle Genetics in 2013.
2013
Clay Siegall
Seattle Genetics
Chief Executive Officer
2013
Eric Dobmeier
Seattle Genetics
Chief Operating Officer
2013
Jonathan Drachman
Seattle Genetics
Chief Medical Officer
2013
Todd Simpson
Seattle Genetics
Chief Financial Officer
2013
Vaughn Himes
Seattle Genetics